Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03670511 Completed - Healthy Clinical Trials

Validation and Predictive Equation for Sit-to-stand Test in Children

Start date: November 2016
Phase: N/A
Study type: Interventional

Validation and development of predictive values for the one minute sit-to-stand test in children between 6 and 18 years.

NCT ID: NCT03661216 Completed - Healthy Clinical Trials

Evaluation of Nephureâ„¢, and the Reduction of Dietary Oxalate, in Healthy Volunteers

Start date: July 11, 2018
Phase: N/A
Study type: Interventional

The purpose of this double-blind study is to determine the effect of reducing oxalates in the diet of healthy volunteers by using Nephure, an oxalate-reducing enzyme, as compared to placebo.

NCT ID: NCT03659994 Completed - Healthy Clinical Trials

Effects of VitaBeard® on Facial Hair Growth in Healthy Adult Men

Start date: January 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine dose-dependent effects of Vitabeard on various parameters of facial hair growth.

NCT ID: NCT03643627 Completed - Healthy Clinical Trials

A Study of SYNT001 in Healthy Volunteers

Start date: August 17, 2016
Phase: Early Phase 1
Study type: Interventional

This study is being done to compare the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of an intravenous (IV) formulation of SYNT001. This is the first-in-human (FIH) study of SYNT001.

NCT ID: NCT03639155 Completed - Healthy Clinical Trials

A Study in Evaluating Bioequivalence Between Test and Reference Formulations of Vadadustat Tablets in Healthy Adults

Start date: April 12, 2018
Phase: Phase 1
Study type: Interventional

This study is to assess the bioequivalence of a test formulation of vadadustat (A) compared to a reference formulation of vadadustat (B)

NCT ID: NCT03638934 Completed - Healthy Clinical Trials

Efficacy of Self-education Program for Advanced Care Planning(RCT) for General Population

Start date: April 27, 2018
Phase: N/A
Study type: Interventional

This study verifies efficacy of Self-education program for advanced care planning in general population. Half of participants will receive a 20 minutes video about advanced care planning while the other half will receive a 13-page brochure entitled, Understanding the Life-Sustaining Treatment Act.

NCT ID: NCT03634137 Completed - Healthy Clinical Trials

Implant Pharmacokinetic and Pharmacodynamic Study

Start date: September 2009
Phase: Phase 1
Study type: Interventional

This is a single center, pharmacokinetic and pharmacodynamic study in healthy volunteers. Twenty four subjects will be enrolled in the study and will be assigned to receive either a 16 mg afamelanotide bioresorbable implant from the current manufacturing process or a 16 mg afamelanotide bioresorbable implant from the optimized manufacturing process. Implants will be administered subcutaneously. The following procedures will be conducted throughout the study: - Collection of blood samples for analysis of afamelanotide concentrations - Measurement of skin reflectance for estimation of melanin density, and luminance (L*), blue/yellow colour hue (b*) - Safety monitoring

NCT ID: NCT03634085 Completed - Healthy Clinical Trials

Single Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of BDM-2 in Healthy Male Subjects.

Start date: May 17, 2018
Phase: Phase 1
Study type: Interventional

This is a first-in-human (FIH), double-blind, placebo-controlled, randomized trial in healthy adult male subjects, to evaluate the safety, tolerability and pharmacokinetics (PK) of single ascending oral doses of BDM-2. The effect of food on the PK of a single dose of BDM-2 will also be evaluated.

NCT ID: NCT03627520 Completed - Healthy Clinical Trials

A Mass Balance Study to Investigate the Absorption, Metabolism, and Excretion of [14C]Sulfatinib

Start date: April 2, 2018
Phase: Early Phase 1
Study type: Interventional

This is a single-center, open label and single-dose clinical trail, to explore the body mass balance and identify the major metabolites in Chinese adult male healthy volunteers after a single oral dose of [14C]Sulfatinib, to obtain the pharmacokinetic parameters of plasma and observe the safety of healthy volunteers after a single oral dose of [14C]Sulfatinib.

NCT ID: NCT03627273 Completed - Healthy Clinical Trials

6MWT With and Without Walker

Start date: July 2014
Phase: N/A
Study type: Interventional

Elderly subjects repeated 6MWT with or without walker